I recently learned that the CeliAction Study will be enrolling subjects with celiac disease through the end of July 2014. The ALV003 enzyme is being studied as a treatment to augment the gluten-free diet by providing protection from gluten cross-contamination. It is also being researched as a treatment for nonresponsive celiac disease. All questions about this post will be answered by a CeliAction Study representative. Thank you for reading! -Jess
Managing celiac disease may be more than just a gluten-free diet.
A clinical research study called the CeliAction Study is researching if an investigational drug – which would be taken as a supplement to an attempted gluten-free diet – improves any symptoms of celiac disease.
You may qualify for the CeliAction Study if you:
• Have been diagnosed with celiac disease by a healthcare professional
• Are attempting to be on a gluten-free diet
• Have experienced at least one moderate or severe symptom of celiac disease in the past month
If you participate in the CeliAction Study, you:
• Will be able to maintain your current diet restrictions
• Will be provided with study-related care at no cost
• Do not need medical insurance to take part
• May be compensated for time and travel
• Will help advance medical research for celiac disease
To learn more about this research study and see if you qualify, visit www.CeliActionStudy.com or call 1-855-3333-ACT.